RNLX Shariah Compliance

Screening Methodology: AAOIFI

lock image
LOCKED

Analyst's Ratings for Renalytix PLC (RNLX)

Based on 5 analysts giving stock ratings to Renalytix PLC in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
40
Buy
40
Hold
20
Sell
0
Strong Sell
0
Renalytix PLC

Renalytix PLC. Stock Analysis RNLX

United States Health Care Nano Cap
Renalytix Plc engages in the manufacturing of medical devices and equipment. The firm is engaged in a field of bioprognosis for kidney health. The firm has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. The Company’s lead product, KidneyIntelX platform, is designed to scale across kidney disease conditions beyond diabetic kidney disease. The company is evaluating a range of indications in chronic kidney disease, cardio-renal disease, chronic kidney disease in diverse populations and COVID-related kidney disease. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Read More

RNLX Chart

Key Statistics of Renalytix PLC (RNLX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.14$0.16

Today's Open

$0.14

Volume

78.20K

P/E Ratio (TTM)

-

Financial Metrics & Statements of Renalytix PLC (RNLX)

  • Per Share Data
  • Ratios
  • Statements
No data

No Data Available!

  • Annual Icon Annual
  • Quarterly Icon Quarterly
No data

No Annual Data Available!

FAQ's for Renalytix PLC (RNLX)

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.